Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
Guardado en:
Autor principal: | Adilia Warris |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/602feba15aa8444493531617dd64e056 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth
por: Naomi A. van Westen-Lagerweij, et al.
Publicado: (2021) -
What is pneumonia?
por: Grant Waterer
Publicado: (2021) -
Clinical Features and Risk Factors for Mortality in Hospitalized Older Adults with Pneumonia
por: Nobuhiko Fukuda, et al.
Publicado: (2021) -
Organizing pneumonia associated with optic neuromyelitis: Coincidental occurrence or causal association?
por: T. Rimpa, et al.
Publicado: (2021) -
A Case Report of Steroid-Resistant Cryptogenic Organizing Pneumonia Managed with Intravenous Immunoglobulins
por: Christian Akem Dimala, et al.
Publicado: (2021)